skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Overview of the LDL receptor: relevance to cholesterol metabolism and future approaches for the treatment of coronary heart disease

Review

(4794) Views  (1634) Full article downloads

Authors: William R Lagor, John S Millar

Published Date December 2009 Volume 2010:3 Pages 1 - 14
DOI: http://dx.doi.org/10.2147/JRLCR.S6033

William R Lagor, John S Millar

Department of Pharmacology, Institute for Translational Research and Therapeutics, University of Pennsylvania, Philadelphia, PA, USA

Abstract: Since the discovery of the low-density lipoprotein (LDL) receptor over 30 years ago manipulation of its activity has been pursued through dietary and pharmacological means with the goal of reducing LDL cholesterol levels. This has proven to be one of the most widely implemented and beneficial interventions to reduce LDL cholesterol levels and the incidence of cardiovascular death. This review provides an overview of the LDL receptor and its role in regulating whole body cholesterol homeostasis and LDL cholesterol levels. New findings on regulation of the LDL receptor are discussed and how they can be used to develop novel therapeutics to reduce cardiovascular risk.

Keywords: VLDL, statins, pcsk9, cardiovascular disease








Readers of this article also read:

In silico modeling of toluene binding site in the pore of voltage-gate sodium channel
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Health literacy and health seeking behavior among older men in a middle-income nation
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography
Editorial
Everolimus-eluting stents: update on current clinical studies